What is TransAKT Ltd?
, through its subsidiary, TransAKT Bio Agritech Ltd.
TAKD · Verdict
Limited reward · elevated risk
TAKD's standout is balance sheet; volatility and profitability weigh on the picture.
Based on 75% data coverage
TAKD · Verdict
Above average
Weak vs peers
-101% return on equity
Earnings -3.3% CAGR
Model-based scoring. For information only — not financial advice.
, through its subsidiary, TransAKT Bio Agritech Ltd. , engages in the research and development of agricultural technology. The company is listed on the PINK in USA, operating in the Financial Services sector, with a market capitalisation of 333.77K.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.